Breaking News

Biosynth Carbosynth & Shengquan Acquire Factory from Kexing Biopharmaceutical

Expands the joint venture’s production capacities significantly.

Author Image

By: Charlie Sternberg

Associate Editor

Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, and Jinan Shengquan Group Share-Holding Co., Ltd. have acquired Kexing Biopharmaceutical Co., Ltd’s raw material factory in Jinan, China.   With this acquisition, Biosynth Carbosynth’s and Shengquan’s joint venture Carbotang expands its production capacities significantly. The more than 30,000 square meter property contains a comprehensive factory building on 5 floors, a demo workshop and a lar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters